Cribstone Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,907
Closed -$515K 408
2020
Q1
$515K Sell
2,907
-214
-7% -$40.3K 0.54% 52
2019
Q4
$597K Sell
3,121
-821
-21% -$148K 0.53% 51
2019
Q3
$663K Sell
3,942
-270
-6% -$44K 0.4% 59
2019
Q2
$705K Sell
4,212
-605
-13% -$83.8K 0.38% 60
2019
Q1
$705K Sell
4,817
-2,351
-33% -$341K 0.37% 61
2018
Q4
$958K Sell
7,168
-59
-0.8% -$9.67K 0.49% 54
2018
Q3
$1.38M Sell
7,227
-54
-0.7% -$9.92K 0.63% 46
2018
Q2
$1.21M Buy
7,281
+365
+5% +$58.6K 0.6% 48
2018
Q1
$1.16M Buy
6,916
+443
+7% +$74.3K 0.57% 50
2017
Q4
$1.06M Sell
6,473
-239
-4% -$42.9K 0.5% 56
2017
Q3
$1.38M Sell
6,712
-136
-2% -$31.6K 0.72% 40
2017
Q2
$1.67M Buy
6,848
+45
+0.7% +$10.6K 0.91% 34
2017
Q1
$1.63M Buy
6,803
+236
+4% +$55K 0.88% 34
2016
Q4
$1.41M Sell
6,567
-449
-6% -$93K 0.86% 32
2016
Q3
$1.63M Buy
7,016
+272
+4% +$66.5K 1% 26
2016
Q2
$1.56M Buy
+6,744
New +$1.55M 0.96% 27

Other funds holding AGN

Cribstone Capital Management's AGN Position: Q2 2020 in Review

Cribstone Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,907 shares — an estimated $515K sold.

Cribstone Capital Management first reported a position in AGN in Q2 2016 and held it in 16 quarters. The position peaked at $1.67M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cribstone Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cribstone Capital Management sold 2,907 Allergan plc shares in Q2 2020, an estimated $515K.
  • Cribstone Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 16 quarters.
  • Cribstone Capital Management's Allergan plc position peaked at $1.67M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cribstone Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.